Featured image of article Therapeutic mRNA – Delivery is still of major interest.

Therapeutic mRNA – Delivery is still of major interest

SOPHIA ANTIPOLIS, France – March 22, 2023 │The Quarterly Report for the Q4 2022 Therapeutic mRNA Patent Monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Let’s focus on one of the most dynamic segments. KnowMade has developed expertise in the field of therapeutic[…]

Featured image of article Are there specific memory technologies claimed in patents that are more suitable than others for artificial intelligence/machine learning (AI/ML) applications?

Are there specific memory technologies claimed in patents that are more suitable than others for artificial intelligence/machine learning (AI/ML) applications?

SOPHIA ANTIPOLIS, France – February 24, 2023 │ KnowMade releases a new report to investigate the patents related to memory technologies for artificial intelligence/machine learning (AI/ML) applications. Creating artificial neurons and synapses using emerging memories In recent years, neuromorphic computing has emerged as a promising technology in the post-Moore’s law era. Neuromorphic computing systems are[…]

Featured image of article Can Chinese players win the 5G race and lead the RF Front End module patent landscape?

Can Chinese players win the 5G race and lead the RF Front End module patent landscape?

SOPHIA ANTIPOLIS, France – November 3, 2022 │ Today, KnowMade is releasing its Q3 2022 quarterly report from its RF Front End Module & Components Patent Monitor, covering PA/LNA, RF filters (SAW, BAW, XBAR), RF switch, RF tuner, and the RF Front End module. Strong acceleration of IP activities from Chinese players For the last[…]